Growth Metrics

Enanta Pharmaceuticals (ENTA) Cash from Investing Activities Growth (3y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 116.52%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.24%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -22.09%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 30.54%
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn - -36.56%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -36.56%
Dec 31, 2025 -50.50%
Sep 30, 2025 -56.67%
Jun 30, 2025 -53.73%
Mar 31, 2025 50.05%
Dec 31, 2024 14.83%
Sep 30, 2024 -35.98%
Jun 30, 2024 47.44%
Mar 31, 2024 32.05%
Dec 31, 2023 9.07%
Sep 30, 2023 67.83%
Jun 30, 2023 -95.24%
Mar 31, 2023 19.00%
Dec 31, 2022 42.64%
Sep 30, 2022 36.45%
Jun 30, 2022 45.69%
Mar 31, 2022 -205.52%
Dec 31, 2021 61.01%
Sep 30, 2021 123.36%
Jun 30, 2021 -11.58%
Mar 31, 2021 57.98%
Dec 31, 2020 -92.44%
Sep 30, 2020 29.43%
Jun 30, 2020 51.78%
Mar 31, 2020 148.60%
Dec 31, 2019 -255.71%
Sep 30, 2019 -104.03%
Jun 30, 2019 22.12%
Mar 31, 2019 69.77%
Dec 31, 2018 -54.90%
Sep 30, 2018 -57.94%
Jun 30, 2018 -80.18%
Mar 31, 2018 27.24%
Dec 31, 2017 -32.92%
Sep 30, 2017 -53.51%
Jun 30, 2017 31.62%
Mar 31, 2017 -52.87%
Dec 31, 2016 -13.77%
Sep 30, 2016 6.98%
Jun 30, 2016 13.30%
Mar 31, 2016 69.34%
Dec 31, 2015 -62.03%
Sep 30, 2015 -23.75%
Jun 30, 2015 38.11%